| Literature DB >> 30655901 |
Hiroshi Kunikane1, Isao Yokota2, Nobuyuki Katakami3, Koji Takeda4, Koichi Takayama5, Toshiyuki Sawa6, Hiroshi Saito7, Masao Harada8, Soichiro Yokota9, Kiyoshi Ando10, Yuko Saito11, Yasuo Ohashi12, Kenji Eguchi13.
Abstract
A prospective study has previously reported on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients with advanced lung cancer. The aim of the present study was to prospectively investigate how the quality of life (QOL) of patients with advanced lung cancer was affected by SREs. Patients with stage IIIB or IV non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) at any stage were followed up every four weeks to determine if they had developed SREs. QOL questionnaires were conducted at enrollment, at 3- and 12-months later and at 1 month after the onset of SREs, using QOL scores including the EuroQOL-5 Dimension (EQ-5D), Functional Assessment of Cancer Therapy-General (FACT-G) and activities of daily living (ADL) scores obtained by the Barthel Index. A total of 274 patients were enrolled in the study. At enrollment the EQ-5D and Barthel Index scores were lower in patients with SREs compared with patients without SREs. A chronological analysis revealed no statistically significant changes in either QOL or ADL in any of the patients. For 14 patients in whom QOL data was collected following the onset of SREs, the evaluation undertaken on the four subscales of the FACT-G revealed a significant decline in emotional functioning following the onset of SREs.Entities:
Keywords: EuroQOL-5 dimension; barthel index; functional assessment of cancer therapy-general; lung cancer; quality of life; skeletal-related event
Year: 2018 PMID: 30655901 PMCID: PMC6312953 DOI: 10.3892/ol.2018.9680
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967